Rapamune 2 mg, überzogene Tabletten
7680558040074
CH-55804
überzogene Tabletten
Associated product:
RAPAMUNE cpr 2 mg 100 pce
1 / 3
google
Article details
- Package size
- 100
- Selling units
- 100
- Measure
- Tablette(n)
- Galenic form
- überzogene Tabletten
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
86.4 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
212.46 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 854.20
Specialties list
Yes
Generic
No
SL addition date:
01/07/2004
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 55804
- Drug name
- Rapamune, überzogene Tabletten
- Galenic form
- UEBT
- ATC Code
- L04AH01
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 14/12/2001
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- RAPAMUNE cpr 2 mg 100 pce
- Description (DE)
- RAPAMUNE Tabl 2 mg 100 Stk
- Market launch
- 27/11/2003
- Narcotic (BTM)
- No